Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base...
Transcript of Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base...
![Page 1: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/1.jpg)
Robin Cusick, MDLifeStream 2019 Transfusion Medicine ForumMarch 9, 2019
Transfusing Patients when All Blood is Incompatible
![Page 2: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/2.jpg)
Roles, Disclosures, & Acknowledgements• Division Chief Medical Officer – Vitalant, Southwest Division
• Medical Director of Vitalant Immunohematology Reference Laboratory – Tempe Lab
• Medical Director for Creative Testing Solutions – Phoenix Lab
• No disclosures
• Many thanks to Dolores Figueroa & Dr. Joe Chaffin
![Page 3: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/3.jpg)
3
What we’ll talk about ‐
• Panreactive crossmatches & the most likely cause
• Appropriate transfusion recommendations when all or most blood is incompatible
• The role of communication when all or most blood is incompatible
![Page 4: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/4.jpg)
Spoiler alert – aka Take Home Points
• Panreactive crossmatches may be caused by autoantibodies, alloantibodies, or patient‐related factors
• Patients should not be denied transfusions if compatible blood is not available or does not exist
• Communication is crucial but it may not be easy
![Page 5: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/5.jpg)
Transfusion Safety
![Page 6: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/6.jpg)
Causes of Panreactivity
Autoantibodies• Underlying allos ruled out
• Underlying allos not ruled out
Alloantibodies to high prevalence antigens
Multiple alloantibodies
Patient-related factors• Disease states
• Drug therapy (e.g. anti-CD38)
![Page 7: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/7.jpg)
Clinical Case
• 73‐year‐old female, PMH of hemolytic anemia
• Presented to ED early Friday morning, brought by husband
• Lab and clinical findings suggestive of and compatible with hemolytic anemia – Hb 4.5 g/dl
• Hem‐Onc consulted, recommended 125 mg of Solu‐Medrol and ordered 2 units of PRBC.
![Page 8: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/8.jpg)
Autoantibodies
Antibodies directed at some aspect of red cells (e.g. – component of membrane)
Usually broad specificity – all cells react• Patient (native and autologous), donor, or reagent red cells
Reactivity of autoantibody varies with temperature
![Page 9: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/9.jpg)
AutoantibodiesCan be idiopathic, due to drugs, or underlying disease
May or may not cause hemolysis
Clinical significance relates to…• Hemolytic potential
• Interference with pre‐transfusion compatibility testing
Sloane 1998, Wheeler et al 2004
![Page 10: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/10.jpg)
Crossmatching blood with autoantibodies
Autoantibodies complicate and prolong blood bank evaluation
Patients may not be able to wait for the conclusion of the work up – may need to be transfused
Usually all blood is crossmatch incompatible – transfusing provider signature required
As laboratory professionals, how we communicate this to the clinical team can be pivotal for the patient!
![Page 11: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/11.jpg)
A quick, high level tour of the blood bank behind the scenes…..
![Page 12: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/12.jpg)
Overview of pretransfusion testing
• ABO determination• Rh determination• Antibody detection/identification • Final crossmatch
Autoantibodies may interfere with any of these steps.
![Page 13: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/13.jpg)
DAT aka Direct Coombs
Direct antiglobulin test (DAT) indicates that something—IgG or complement—is already coating the cells.
Direct Antiglobulin Test
Poly IgG C36%Alb.
IS 3+ 3+ 0 0RT NT 0 0
![Page 14: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/14.jpg)
Antibody screen and panel cells will show panreactivityand positive autocontrol
Now the BB needs to rule out underlying alloantibodies…
![Page 15: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/15.jpg)
15
Excluding Underlying Alloantibodies
![Page 16: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/16.jpg)
Clinicopathologic Correlation
• Thorough blood bank evaluations can be very time‐consuming.
• Communication between lab and clinical team is essential.
![Page 17: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/17.jpg)
To Transfuse or Not to Transfuse?
If patient is stable, best to avoid transfusion
But…transfusion should not be delayed for completion of work‐up if patient is clinically unstable!
If transfusion is indicated, • Transfuse slowly and give the smallest amount needed • May consider pharmacologic “cover”
![Page 18: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/18.jpg)
Clinical case, continued
• ~15 h later (1 am on Saturday), ICU physician called lab wanting to know when compatible blood would be available.
• Patient Hb at that time was ~3.9 g/dl.
• Once clinical team understood that compatible blood was not possible, ICU MD signed for 2 units ‘least incompatible’ PRBC to be transfused.
• Patient tolerated transfusion but did not survive hospital course.
![Page 19: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/19.jpg)
Pathologists and laboratory staff can impact these situations.
Presented to ER with Hb 4.5 g/dl, transfusion recommended
All blood incompatible –extensive lab
w/u in progress
Patient receives blood ~18 h
later, Hb 3.9 g/dl
![Page 20: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/20.jpg)
Patients without preexisting cardiovascular disease:• If no significant s/sx of anemia or hypoxia, avoid RBC transfusion when Hb is > 7‐8 g/dl.
Patients with preexisting cardiovascular disease• If no significant s/sx of anemia or hypoxia, avoid RBC transfusion when Hb is > 8 g/dl.
No consensus on hemodynamically stable patients with acute coronary syndrome ‐ base transfusion decisions on patient factors as well as laboratory data.
![Page 21: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/21.jpg)
• Retrospective study of 300 patients who refused transfusion for religious reasons
• 30 day in‐hospital mortality with postoperative hemoglobin levels:
• 7.1 to 8: 0% (9.4% Morbidity)
• 5.1 to 7: 9%
• 3.1 to 5: 30%
• <3.0: 64%
![Page 22: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/22.jpg)
Oxygen delivery physiology
Normal oxygen consumption to oxygen delivery ratio is 0.20 to 0.25• Anaerobic metabolism begins when ratio reaches 0.50
Normal individuals can reduce Hb to 3.5 to 4 g/dl before extraction to delivery ratio increases to 0.50• In models of coronary stenosis, anaerobic state (aka ratio of 0.50) occurs at Hb ~6 ‐ 7 g/dl
![Page 23: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/23.jpg)
Risks per Unit Transfused
![Page 24: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/24.jpg)
ASCP Case Reports TM‐16‐7 Cusick, 2016, www.ascp.org
How We Can Help
![Page 25: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/25.jpg)
Autoantibodies: what information would we ideally have?
RBC phenotype• Use to provide phenotypically matched RBC for Rh and K antigens
Are there underlying antibodies present?• If yes, provide antigen negative units• Regardless, all crossmatches will still be incompatible!
![Page 26: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/26.jpg)
Autoantibodies: How will we proceed?
If patient cannot wait,
• Transfuse ABO compatible RBCs• Give phenotypically matched RBC for Rh and K antigens
If patient can wait, there are options,
• Give phenotypically matched RBC for Rh and K antigens
• Adsorptions to rule out underlying allos
![Page 27: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/27.jpg)
Causes of Panreactivity
Autoantibodies• Underlying allos ruled out
• Underlying allos not ruled out
Alloantibodies to high prevalence antigens
Multiple alloantibodies
Patient-related factors• Disease states
• Drug therapy (e.g. anti-CD38)
![Page 28: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/28.jpg)
Alloantibodies to high prevalence antigens
May be nuisance only – e.g. HTLA
May be clinically significant or variably clinically significant• Anti-Vel
• Anti-Dib
• Anti-U
• Anti-Yta
![Page 29: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/29.jpg)
Harmening, Modern Blood Banking & Transfusion Practices – 6th ed
![Page 30: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/30.jpg)
A bird in hand is worth two in the bush…
Even if compatible units exist, they are only helpful if• they are immediately available or
• the patient can wait for them
![Page 31: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/31.jpg)
If patient can wait, there are options• Import unit from sister center
• Rare unit search• Rare donor recruitment
• Sibling recruitment
• Obtain MMA
If patient cannot wait, give ABO compatible RBCs
Patients with ab to high prevalence antigens: how will we proceed?
![Page 32: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/32.jpg)
Monocyte Monolayer Assay (MMA)
What it is: an predictive, in vitro assay to get an estimate of how clinically significant a particular antibody is
What it is good for: helpful in situations when patients will be transfused with an antigen corresponding to their antibody
What it is not good for: situations requiring urgent resolution or rapid TAT
![Page 33: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/33.jpg)
Monocyte Monolayer Assay (MMA)
Figures from Dr. Ghislain Noumsi ‐ SCABB presentation
![Page 34: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/34.jpg)
Interpretation of the MMA
![Page 35: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/35.jpg)
Causes of Panreactivity
Autoantibodies• Underlying allos ruled out
• Underlying allos not ruled out
Alloantibodies to high prevalence antigens
Multiple alloantibodies
Patient-related factors• Disease states
• Drug therapy (e.g. anti-CD38)
![Page 36: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/36.jpg)
Panel with Multiple Alloantibodies
•Anti‐c•Anti‐E•Anti‐S•Anti‐Fya
•Anti‐Jkb
![Page 37: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/37.jpg)
Patients with ab to multiple antigens: how will we proceed?
If patient cannot wait, transfuse ABO compatible RBCs
If patient can wait, there are options• Obtain unit from sister center
• Rare unit search• Donor recruitment
• Sibling recruitment
• MMA is not as useful in this situation
![Page 38: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/38.jpg)
Between 2005 and 2012, ARDP had 6834 requests for rare units
33% of these were for multiple common alloantibodies• 67% were antibodies to high prevalence antigens
6% of requests were unfilled ‐ inadequate supply• Sickle cell patients – 16%• “Highs” – 8%
![Page 39: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/39.jpg)
A bird in hand is worth two in the bush…
Even if compatible units exist, they are only helpful if• they are immediately available or
• the patient can wait for them
![Page 40: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/40.jpg)
Causes of Panreactivity
Autoantibodies• Underlying allos ruled out
• Underlying allos not ruled out
Alloantibodies to high prevalence antigens
Multiple alloantibodies
Patient-related factors• Disease states
• Drug therapy (e.g. anti-CD38, anti-CD47)
![Page 41: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/41.jpg)
41
Patient Factors: Rouleaux
Erythrocytes seem to overlap one another
Correlate with clinical findings
Aggregation interferes with pretransfusion compatibility testing• ABO discrepancies, falsely positive DATs, falsely positive serologic crossmatches
![Page 42: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/42.jpg)
42
Patient Factors: Rouleaux
Use saline replacement technique (AABB TM) to replace plasma with saline and complete the pretransfusion compatibility testing.• True antibody‐mediated agglutination will not disperse with saline replacement
• Adherent RBCs of rouleaux will separate
Electronic crossmatch, IS crossmatch with saline replacement, or a full serologic crossmatch using AHG are options.
![Page 43: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/43.jpg)
Patient Factors: Multiple myeloma, and monoclonal anti‐CD38 therapy
![Page 44: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/44.jpg)
Communication is essential
• Hospital blood banks and reference labs must be notified that a patient has received anti‐CD38 therapy.
• Type & screen and obtain phenotype for patients prior to starting treatment
• If urgent transfusion is required, transfusions should not be withheld
![Page 45: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/45.jpg)
Anti‐CD47 – a new monoclonal IgG4 antibody
To mitigate, BB options include…• Requesting drug history for patients requiring transfusions
• Performing multiple RBC alloadsorptions
• Using monoclonal Gamma-clone IgG for IAT ABID - does not detect IgG4s like anti-CD47
![Page 46: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/46.jpg)
![Page 47: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/47.jpg)
ASCP Case Reports TM-16-7
Cusick, 2016 www.ascp.org
Summary of
Key Findings in
“Tough”
Crossmatches
![Page 48: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/48.jpg)
ASCP Case Reports TM‐16‐7 Cusick, 2016 www.ascp.org
High Level
Approach to
Managing
“Tough”
Crossmatches
![Page 49: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/49.jpg)
How We in the Laboratory Can Help
![Page 50: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/50.jpg)
Crucial Conversations
What are they?
Ideally who would facilitate them?
Is there any back up?
![Page 51: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/51.jpg)
51
What are the additional resources?Blood center medical director • (24/7/365 coverage)
IRL or reference lab medical director• (24/7/365 coverage)
Additional hospital physicians (Hem‐Onc, Anesthesia, Critical Care)
These resources are available to support hospital BB medical directors, cross‐covering pathologists, and hospital laboratory staff
![Page 52: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/52.jpg)
Success! The treating team agrees to take emergency release units for our patient who has no compatible blood available.
Now what?
![Page 53: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/53.jpg)
During the transfusion…• Adhere to hospital policy re: release of incompatible blood
• Follow usual blood administration procedures
• Consider pharmacologic “coverage”
• Transfuse slowly and least amount possible
• Watch for signs/symptoms of a transfusion reaction
• If a transfusion reaction occurs, follow routine procedures
![Page 54: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/54.jpg)
• IVIG – established usage in hyperhemolysis
• IVIG use in non-ABO incompatible RBC transfusion less established
• Dosage not standardized
• HH high dose/low dose regimen can be applied
• Steroids may have synergistic effect on IVIG
• Dosage not standardized
• Most reported cases use IVIG and steroids
![Page 55: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/55.jpg)
After the transfusion…
Patients should be monitored for signs/symptoms of a delayed reaction• Delayed serologic transfusion reaction• Delayed hemolytic transfusion reaction
Communication between lab and clinical team can prevent an extensive FUO work up.
![Page 56: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/56.jpg)
In Summary
Panreactive crossmatches may be caused by autoantibodies, alloantibodies, or patient‐related factors
Patients should not be denied transfusions if compatible blood is not available or does not exist
Communication is crucial but it may not be easy
![Page 57: Patients when All Blood is Incompatible · g/dl, transfusion recommended All blood ... ‐base transfusion decisions on patient factors as well as laboratory data. • Retrospective](https://reader034.fdocuments.net/reader034/viewer/2022042709/5f54ce0f84727c0fab3f113a/html5/thumbnails/57.jpg)
“Thank you!”